Ticker Symbol: GTBP
GT Biopharma Inc
$5.00 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0000109657
Company Profile
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based our proprietary TriKE™ NK cell engager platform. Our TriKE™ platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). GT Biopharma has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE™ technology.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 310 N Westlake Blvd Ste 206
Website: www.gtbiopharma.com
CEO: Anthony Cataldo
Tags:
- Pharmaceuticals: Other
- Health Technology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $0.25
Change:
$0.00
(
1.88%)
Days Range: $0.24 - $0.26
Beta: 1.29
52wk. High: $2.29
52wk. Low: $0.17
Ytd. Change -69.33%
50 Day Moving Average: $0.25
200 Day Moving Average: $0.30
Shares Outstanding: 40639688
Valuation
Market Cap: 1.0B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A